From Concept to Global Reality
A curated view of the ventures, funds, and initiatives NAZR Ventures has helped create, capitalise, and bring to market — across healthcare, oncology, frontier technology, and sustainable infrastructure.
Our Work
Building Ventures That Matter
NAZR Ventures partners with founders, institutions, and capital partners at every stage of the venture lifecycle — from formation and fundraising through to global commercialisation. The ventures below represent a cross-section of our active, in-progress, and completed work.
Advanced Oncology Infrastructure Fund
A dedicated global investment fund building the strategic, operational, and capital infrastructure required to advance oncology at scale. The fund targets precision diagnostics, next-generation therapeutics, immunotherapy platforms, and the clinical infrastructure needed to deliver transformative oncology solutions to patients across multiple continents. Open to qualified institutional investors, family offices, and sovereign capital partners seeking meaningful exposure to one of the world's most critical healthcare sectors.
Health Innovation Fund
A dedicated health innovation fund now open to investors — connecting institutional capital, family offices, and sovereign partners around a focused mandate to back transformative healthcare ventures across diagnostics, therapeutics, digital health, and life sciences. The fund is actively deploying capital into a curated portfolio of high-potential companies at the frontier of healthcare innovation.
Healthcare Infrastructure Fund
An open fund facilitating the development and financing of next-generation healthcare infrastructure — combining smart facility design, digital integration, and sustainable operations to build the physical and technological backbone that advanced healthcare systems require. Now open to institutional investors, family offices, and strategic capital partners seeking long-term exposure to healthcare infrastructure across the GCC and MENA.
Autonomous Robotic Surgery System & AI Brain
Strategic partner and capital facilitator for a next-generation autonomous robotic surgery system and its proprietary AI brain — an intelligent platform that enables real-time surgical decision support, autonomous instrument guidance, and adaptive procedural learning. The system and its AI core are in active development, with a total addressable raise of $250M. Supporting the venture across investor access, strategic partnerships, and global market entry — targeting leading hospital systems, surgical centres, and healthcare networks worldwide.
Cancer Therapy Centers
Partnering on the development and international expansion of specialised cancer therapy centres, integrating precision oncology, immunotherapy, and multidisciplinary care models. The network spans the GCC, Africa, Asia-Pacific, and North America — bringing world-class cancer care to underserved and high-growth markets.
Preventive Health Ecosystem — Global Deployment
Strategic partner supporting the global deployment of a comprehensive preventive health ecosystem — a cloud-enabled platform that delivers accessible, personalised preventive care to individuals, communities, and organisations worldwide. The platform integrates digital health tools, clinical protocols, and wellness pathways to fundamentally shift healthcare from reactive treatment to proactive prevention at scale, with deployment underway across multiple international markets.
Integrated Cell & Gene Therapy Platform
Co-developing what is positioned to be the world's first fully integrated cell and gene therapy platform — combining manufacturing, clinical delivery, and commercial infrastructure into a single, end-to-end system. The platform is designed to accelerate the translation of advanced cell and gene therapies from research into scalable, globally accessible treatments.
Cell & Gene Therapy Infrastructure
Facilitating the development of dedicated cell and gene therapy manufacturing and delivery infrastructure to support the scaling of advanced therapeutic programmes — connecting facility development, regulatory strategy, and capital formation across the GCC and Europe.
AI-Driven Clinical Workflow Platform
Venture creation and market entry support for an AI-powered clinical workflow automation platform targeting hospital systems across the MENA region.
Health, Wellness & Preventive Platform
Jointly created a comprehensive health, wellness, and preventive care platform integrating biomarker diagnostics, metabolic health, and personalised wellness protocols. Successfully facilitated a $10M Series A round for this global brand, connecting the founding team with aligned institutional and strategic investors.
MedTech Market Entry — GCC
Led the full GCC market entry strategy for a European MedTech company, including regulatory navigation, distributor partnerships, and hospital procurement engagement across the UAE, KSA, and Qatar.
Digital Health Venture — Series B
Provided strategic advisory and investor access support for a digital health venture through a successful Series B raise, connecting the founding team with regional family offices and institutional investors.
Sector Focus
Where We Operate
Working on Something Transformative?
We partner with founders and institutions at every stage — from early formation to global scale.